Recent pulmonary observations in alpha 1-antitrypsin deficiency, primary biliary cirrhosis, chronic hepatitis C, and other hepatic problems.
Patients with metabolic, immunologic, viral, and other types of hepatic disorders can have a spectrum of complicating pulmonary abnormalities. The natural history of these associations is poorly understood. Significant reversibility in hepatic and pulmonary dysfunction, however, has been well documented in the era of organ transplantation. The continued relationship among pulmonologists, hepatologists, and transplant surgeons hopefully will provide enlightening data on these interesting clinical associations, their natural histories, and their response to evolving therapeutic approaches.
Krowka
M J
MJ
Mayo Medical School, Mayo Clinic Jacksonville, Florida, USA.
D002908:Chronic Disease; D006526:Hepatitis C / Q000150:complications* / Q000601:surgery; D006801:Humans; D008105:Liver Cirrhosis, Biliary / Q000150:complications* / Q000601:surgery; D008107:Liver Diseases / Q000150:complications / Q000601:surgery; D016031:Liver Transplantation; D008171:Lung Diseases / Q000209:etiology* / Q000503:physiopathology / Q000601:surgery; D016040:Lung Transplantation; D008661:Metabolism, Inborn Errors / Q000150:complications* / Q000601:surgery; D010996:Pleural Effusion; D011379:Prognosis; D012042:Registries; D012129:Respiratory Function Tests; D019896:alpha 1-Antitrypsin Deficiency